By combining CRISPRi screen with orthogonal multiomics approaches, we identified a lncRNA DARS1-AS1–controlled posttranscriptional circuitry that promoted the malignant properties of GBM cells/GSCs. This evidence concerns the gene DARS1 and glioblastoma.